Synonyms: KB-003 | KB003
Compound class:
Antibody
Comment: Lenzilumab is a fully human IgG1κ moncolonal antibody targeting granulocyte-macrophage colony-stimulating factor (GM-CSF), being investigated for its immunomodulatory potential.
Peptide sequences for this antibody are available from its IMGT/mAb-DB record. BLAST peptide searches using the variable regions of the heavy and light chains of the antibody reveal exact matches with sequences submitted with patent US8075885 B2 [1]. |
Classification | |
Compound class | Antibody |
International Nonproprietary Names | |
INN number | INN |
9965 | lenzilumab |
Synonyms |
KB-003 | KB003 |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 505 |
Other databases | |
GtoPdb PubChem SID | 310264716 |
Search PubMed clinical trials | lenzilumab |
Search PubMed titles | lenzilumab |
Search PubMed titles/abstracts | lenzilumab |